User:Mr. Ibrahem/Isatuximab

Isatuximab, sold under the brand name Sarclisa, is a medication for the treatment of multiple myeloma. It is used in people who have failed other treatments. It is given by gradual injection into a vein. It is often used together with dexamethasone and diphenhydramine.

Common side effects include low neutrophils, infusion reactions, pneumonia, nose and throat infections, diarrhea, and bronchitis. Other side effects may include anaphylaxis, and other types of cancer. Use in pregnancy may harm the baby. It is a monoclonal antibody (mAb) that attaches to CD38, which is commonly found on myeloma cells.

Isatuximab was approved for medical use in the United States and Europe in 2020. In the United Kingdom 500 mg cost the NHS about £2,500 as of 2021. In the United States this amount costs about 3,600 USD.